Related Experiment Video
Updated: Feb 16, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Targeting pattern-recognition receptors to discover new small molecule immune modulators
Gengzheng Zhu1, Yao Xu1, Xiaohong Cen1
1Guangdong Provincial Key Laboratory of New Drug Screening and Guangzhou Key Laboratory of Drug Research for Emerging Virus Prevention and Treatment, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China.
Small molecule regulators targeting pattern recognition receptor (PRR) signaling pathways, including Toll-like receptors (TLRs), RIG-I-like receptors (RLRs), and NOD-like receptors (NLRs), are crucial for modulating innate and adaptive immunity against pathogens.
Area of Science:
- Immunology
- Molecular Biology
- Pharmacology
Background:
- Pattern recognition receptors (PRRs) are essential for innate immunity, detecting pathogen-associated molecular patterns (PAMPs).
- PRRs exhibit universal expression, rapid responses, and broad microbial recognition, distinguishing them from adaptive immune receptors.
- Key PRR families include Toll-like receptors (TLRs), RIG-I-like receptors (RLRs), C-type lectin receptors (CLRs), and NOD-like receptors (NLRs).
Purpose of the Study:
- To review the impact of small molecule regulators on PRR-initiated signaling pathways.
- To explore how these regulators influence innate and adaptive immune responses.
- To highlight therapeutic potential in modulating immune responses via PRR pathways.
Main Methods:
- Literature review focusing on small molecule modulators of TLR, RLR, and NLR signaling.
- Analysis of signaling cascades downstream of PRR activation.
- Examination of effects on immune cell activation and cytokine production.
Main Results:
- PRR activation triggers signaling pathways involving adaptor proteins, leading to NF-κB, MAP kinase, and IRF activation.
- These pathways control the transcription of pro-inflammatory genes, including type I interferon and cytokines.
- Small molecules can modulate these signaling events, impacting both innate and adaptive immunity.
Conclusions:
- Small molecule regulators offer a promising avenue for therapeutic intervention by targeting PRR signaling.
- Modulation of TLR, RLR, and NLR pathways can be leveraged to enhance or suppress immune responses.
- Understanding these interactions is critical for developing novel immunotherapies.
Related Concept Videos
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...

